EZH2 expression is associated with high proliferation rate and aggressive tumor subgroups in cutaneous melanoma and cancers of the endometrium, prostate, and breast.
about
Epigenetic modifications in cancerH3K27 demethylation by JMJD3 at a poised enhancer of anti-apoptotic gene BCL2 determines ERα ligand dependencymiR-101 is down-regulated in glioblastoma resulting in EZH2-induced proliferation, migration, and angiogenesisEZH2 methyltransferase and H3K27 methylation in breast cancerOne-Carbon Metabolism in Prostate Cancer: The Role of Androgen SignalingPolycomb repressive complex's evolutionary conserved function: the role of EZH2 status and cellular backgroundTargeting EZH2 in cancerProgress in epigenetic histone modification analysis by mass spectrometry for clinical investigationsPolycomb Group (PcG) Proteins and Human Cancers: Multifaceted Functions and Therapeutic ImplicationsCommon features of chromatin in aging and cancer: cause or coincidence?Epigenetics in breast cancer: what's new?Targeting activating mutations of EZH2 leads to potent cell growth inhibition in human melanoma by derepression of tumor suppressor genesPrognostic value of high EZH2 expression in patients with different types of cancer: a systematic review with meta-analysisEZH2 as a mediator of treatment resistance in melanomaCurrent Status of Long Non-Coding RNAs in Human Breast CancerEZH2 in Bladder Cancer, a Promising Therapeutic TargetDiverse involvement of EZH2 in cancer epigeneticsEpigenetic regulation in human melanoma: past and futurePotential epigenetic mechanism(s) associated with the persistence of psychoneurological symptoms in women receiving chemotherapy for breast cancer: a hypothesisMAGE-C2/CT10 protein expression is an independent predictor of recurrence in prostate cancerPRC2/EED-EZH2 complex is up-regulated in breast cancer lymph node metastasis compared to primary tumor and correlates with tumor proliferation in situEZH2 codon 641 mutations are common in BCL2-rearranged germinal center B cell lymphomasPolycomb silencers control cell fate, development and cancerRole of YY1 in the pathogenesis of prostate cancer and correlation with bioinformatic data sets of gene expressionExpression of polycomb group protein EZH2 in nevi and melanoma.Genome-wide profiling of histone h3 lysine 4 and lysine 27 trimethylation reveals an epigenetic signature in prostate carcinogenesis.CDKN1C (p57) is a direct target of EZH2 and suppressed by multiple epigenetic mechanisms in breast cancer cellsKi-67 expression is superior to mitotic count and novel proliferation markers PHH3, MCM4 and mitosin as a prognostic factor in thick cutaneous melanoma.The Sex-determining region Y-box 4 and homeobox C6 transcriptional networks in prostate cancer progression: crosstalk with the Wnt, Notch, and PI3K pathwaysEZH2: not EZHY (easy) to deal.Dietary omega-3 polyunsaturated fatty acids suppress expression of EZH2 in breast cancer cells.The Bmi-1 polycomb protein antagonizes the (-)-epigallocatechin-3-gallate-dependent suppression of skin cancer cell survival.Enhancer of zeste homolog 2 (EZH2) expression is an independent prognostic factor in renal cell carcinomaComprehensive evaluation of the role of EZH2 in the growth, invasion, and aggression of a panel of prostate cancer cell linesNFIB Mediates BRN2 Driven Melanoma Cell Migration and Invasion Through Regulation of EZH2 and MITF.Promoter hypomethylation of EpCAM-regulated bone morphogenetic protein gene family in recurrent endometrial cancerEZH2 and STAT6 expression profiles are correlated with colorectal cancer stage and prognosis.Genetics and epigenetics of the skin meet deep sequence.Role of EZH2 in cancer stem cells: from biological insight to a therapeutic target.Superior efficacy of a combined epigenetic therapy against human mantle cell lymphoma cells.
P2860
Q22242610-9EEE8F71-BB0D-40D1-B514-0296E336BA1AQ24322697-C964A5B2-83B4-437C-81C1-0ED2492086DBQ24604354-219FB232-0305-49D3-B096-99ADD792FFE0Q24633788-5E61B545-4BD4-442F-99E5-3E129BA7226EQ26740548-890CC88B-549E-4C0A-B956-42E6051343A5Q26745416-7451D66D-830B-4418-8F8F-FC6F5642B497Q26769027-3E08CED9-E4B5-4E7B-9F22-A4B495EF8CFDQ26781745-042E3F05-BA7C-45C9-BF6C-EEB5C8F69097Q26801380-9A540C16-41BA-46F4-B838-2AA73AD306BBQ26864051-A19AA605-DDC5-4B1E-9391-10B34BD5D632Q26991779-519D7B48-3097-4FEC-8293-2861C5736CE2Q27853201-7AD7F06F-4216-4704-8C35-BC1BEF656919Q27853296-685726D7-0133-4342-8ABF-C030CA2CF9C0Q28074492-08DFCB02-9BDA-4ADB-A0AD-9FD1E7070B6FQ28079880-D5CF2D4F-6A19-4AC4-9A9C-519447819B49Q28082054-318D89E9-33B2-42E8-B946-B172BF167275Q28084911-06402270-AA7B-4FF9-ABD3-697ACEE06653Q28085681-BF180BEB-BC7C-4C04-A32E-FA6E2E3F984CQ28393302-E88B73FD-D8DB-4978-AB54-0EFB44620DC6Q28478930-53E831AA-EF9C-4111-BA59-CE1EB367B3BBQ28484272-0A8010C2-FA9A-40A4-8AC3-79ED081AF638Q28741454-4836BCBA-9158-40AD-876E-EE58A26DF64CQ29619697-C34B946C-F8A8-4610-93DF-59E7F76C8F97Q30838103-ABEE934B-D663-4AA4-BD66-4B0FCBE8A5F8Q33291217-B95D6D0A-AA1E-425E-88CC-0659A7CA8088Q33415036-9DB11E52-B87C-4E00-B1C9-0FE9A610B8F1Q33425892-8A96F49B-EC49-4974-BA75-DE0DD95D56EFQ33557480-2F733693-C5A8-496C-B382-4EF9001659CBQ33597010-E5EF2190-3DCB-4146-8529-7FAB89968462Q33610902-B8D8E47A-F1DC-4D6E-ACFE-5F16058C3922Q33705232-F4A5BC5E-A16D-40A7-A43D-807371F7497FQ33705252-2A3EDC9F-9D59-41F9-95AB-9DA7662BE70BQ33710169-46A1A4F0-55D2-44B1-9CB7-4588FE79580FQ33766326-46EEC246-B684-4467-AFF4-AE88ED302452Q33809465-0BD8DEC1-209F-4D8E-AEEF-4C75D7017156Q33841409-C2149429-1A65-41C7-B85D-467AF39B9D1CQ33867376-35C94050-3D2E-4140-8DAF-1B6826E09084Q33904361-5E9457C5-3514-4FF4-8BDD-206DFCA1D146Q33914216-A5B5289D-5DBF-4638-B493-E5144331EB60Q33959993-92A0F5C4-57AF-4946-B1CB-757B323C6C01
P2860
EZH2 expression is associated with high proliferation rate and aggressive tumor subgroups in cutaneous melanoma and cancers of the endometrium, prostate, and breast.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
EZH2 expression is associated ...... metrium, prostate, and breast.
@en
EZH2 expression is associated ...... metrium, prostate, and breast.
@nl
type
label
EZH2 expression is associated ...... metrium, prostate, and breast.
@en
EZH2 expression is associated ...... metrium, prostate, and breast.
@nl
prefLabel
EZH2 expression is associated ...... metrium, prostate, and breast.
@en
EZH2 expression is associated ...... metrium, prostate, and breast.
@nl
P2093
P356
P1476
EZH2 expression is associated ...... metrium, prostate, and breast.
@en
P2093
Arie P Otte
Helga B Salvesen
Ingeborg M Bachmann
Ingunn M Stefansson
Karin Collett
Oddbjørn Straume
Ole J Halvorsen
Svein A Haukaas
P304
P356
10.1200/JCO.2005.01.5180
P407
P577
2005-12-05T00:00:00Z